LUPKYNIS (U.S. Trademark Serial Number 90306989) is a United States trademark of Aurinia Pharmaceuticals Inc.. The goods and services include: The mark consists of the stylized wording LUPKYNIS to the top right of two half arrows pointing up. The color gray in the mark represents shading and is not a part of the mark. Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis The wording LUPKYNIS has no meaning in a foreign language.. The correspondent is Matthew R. Wilmot of STOEL RIVES LLP.

This trademark was filed on November 09, 2020 as United States Trademark Application Serial Number 90306989. The trademark application was registered on February 15, 2022 as U.S. Trademark Registration 6642346.

Trademark PTO Status History

February 15, 2022 – REGISTERED-PRINCIPAL REGISTER

November 30, 2021 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

November 30, 2021 – PUBLISHED FOR OPPOSITION

November 10, 2021 – NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

October 21, 2021 – APPROVED FOR PUB – PRINCIPAL REGISTER

October 21, 2021 – EXAMINER’S AMENDMENT ENTERED

October 21, 2021 – NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

October 21, 2021 – EXAMINERS AMENDMENT E-MAILED

View full trademark status information at USPTO

Ownership History

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.